AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 271 min read$JHX

Skelly Jonathan sold $2.0M of JHX

Skelly Jonathan (Pres. James Hardie NA) sold 65,000 shares of James Hardie Industries plc (JHX) at an average of $30.46 ($30.45–$30.46, $1.98M total) across 2 trades on 2026-08-25.

Original reporting
SEC EDGAR · Skelly Jonathan
Published Aug 27, 2026, 11:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$JHX
Bearish
medium confidence
Mentioned
$JHX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JHXBearishLow
01

Why it matters

Direct insider sell provides fresh data for traders assessing JHX.

02

Market read

New insider sale may influence short-term trading sentiment for JHX.

03

What to watch

Sale could be part of a pre-arranged liquidity plan unrelated to company fundamentals.

Relevance 6/10Novelty 7/10Timing: filed today

Background

Form 4 filing discloses insider transactions to the SEC.

Company-level read

Ticker impact

$JHXBearishMedium confidence
Context

Officer Skelly Jonathan sold 65,000 shares for $1.98M, reducing his stake to 309,906 shares.

Expected impact

Potential short-term pressure on JHX price.

Evidence & confidence

Officer-level insider sale of nearly $2M is material; market may interpret as a negative signal.

Market effects

Sector

Minimal impact on building materials sector.

Regional

Limited to investors tracking JHX.

Global

Low

Counterpoint

What could challenge this read

Insider may be diversifying; sale does not necessarily indicate negative outlook.

Key entities

  • Company
    James Hardie Industries plc

    Building materials manufacturer listed on NYSE under ticker JHX.

  • Officer
    Skelly Jonathan

    President of James Hardie North America.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

JHX insider trading history →

Related articles

SEP 18
$JHXMedAI 8/10

James Hardie (JHX) Crushes Guidance and Raises Its Full-Year Outlook

James Hardie (JHX) reported Q1 FY2027 results with net sales up 64% YoY to $1.475B, adjusted EBITDA up 79% to $422.1M, and raised full-year guidance. The company cited strong execution, cost synergies from the AZEK acquisition, and share gains in its core business. CEO Aaron Erter noted the beat was not due to housing market improvement. Free cash flow doubled to $254.2M, used to pay down debt. Shares trade at a forward P/E of 21.79.

insidermonkey.com4 min
SEP 16
$JHXMed

James Hardie upgrades FY27 cash flow guidance but not earnings, shares dip 5%

James Hardie (JHX) raised its FY27 free cash flow guidance by 20% to ~US$600M, but shares fell 5% as sales and earnings guidance remained unchanged. The company expects to achieve US$125M in cost synergies a year ahead of schedule. Management stated the guidance does not assume a housing recovery. FY26 free cash flow was US$425M, after deal and integration costs of ~US$207M.

marketindex.com.au2 min